Park, J.H., Choi, S.H. and Chung, J.W. (2013) The Impact of Early Adequate Antimicrobial Therapy on 14-Day Mortality in Patients with Monomicrobial Pseudomonas aeruginosa and Acinetobacter baumannii Bacteremia. Journal of Infection and Chemotherapy, 19, 843-849.
http://dx.doi.org/10.1007/s10156-013-0571-3

has been cited by the following article:

• TITLE: Bacteremia Caused by Acinetobacter baumannii: Epidemiologic Features, Antimicrobial Susceptibility, and Outcomes

  AUTHORS: Tom Chiang, Mina Pastagia, David B. Huang

  KEYWORDS: Acinetobacter baumannii; Bacteremia

  JOURNAL NAME: Advances in Infectious Diseases, Vol.4 No.1, March 17, 2014

  ABSTRACT: Acinetobacter baumannii bacteremia is becoming more prevalent and is associated with increasing morbidity and mortality. Escalating antibacterial resistance further contributes to therapeutic dilemmas, enhanced infection control support and poorer outcomes in patients infected with these bacteria. A retrospective analysis of patients whose blood cultures produced A. baumannii from January 2007 through January 2013 was performed. Data regarding the epidemiologic features, antimicrobial susceptibility and outcomes of patients with A. baumannii bacteremia were collected and analyzed. Sixty A. baumannii isolates each from a different patient were identified. The Charlson Comorbidity Index (≥3) was the greatest among patients with multi-drug resistance (MDR) compared to intermediate drug resistance (IDR) and pan-sensitive (PS) A. baumannii. The mean APACHE II scores for MDR, IDR and PS A. baumannii bacteremia were 21, 15 and 11, respectively (P